Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Cancer > Liver

Diagnosis > Diagnostic test accuracy

Gastroenterology & hepatology > Cancer: other gastrointestinal

Published:

18 May 2020

Authors:

Tang A, McInnes M, Hope TA, Vu K-N, Amre D, Wolfson T, Roy C, Mâsse BR, Sirlin C

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Tang A, McInnes M, Hope TA, Vu K-N, Amre D, Wolfson T, Roy C, Mâsse BR, Sirlin C. Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No.: CD012766. DOI: 10.1002/14651858.CD012766.pub2.